| Prefecture |
Organization |
Institute Director |
Introduction of your Technology, Product and Study |
Technology Classification/Product Classification |
Contact |
| Enterprise |
ASUBIO PHARMA CO., LTD.
|
Seiichi Yokoyama
|
We are a pharmaceutical company specializing in research development within the Daiichi Sankyo Group. With our enterprise is focused on a core function for drug discovery, we conduct screening for novel drug candidate, development research, and preclinical testing. Starting off in 1979 as the Pharmaceutical Division in Suntory Holding Limited, we exploit our experience of launching 6 novel drugs, hold strength in our free, vigorous, and aggressive company climate, and are striving to discover exquisite new drugs by pursuing on our creative research development. |
[Technology Classification]
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
-BA04/Life Innovation/Drug Discovery & Diagnosis/Drugs (Glyco Protein)
-BB08/Life Innovation/Regenerative Medicine/Heart
[Product Classification]
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-78-306-5500
https://www.asubio.co.jp/cgi/form/contact |
| Enterprise |
Biomarker Science Co., Ltd
|
Kagehiro Uchida
|
Biomarker Science (BMS) has identified many biomarkers that can be used for assessing disease-onset-risk by extensive pretomics studies. BMS has also developped "LOX index", a novel predictive biomarker for coronary heart disease and stroke (Clinical Cemistry 56: 4, 550-551,2010). BMS has been implementing contract studies to evaluate potential benefits of functional food materials to reduce disease-onset-risk. BMS is aiming to introduce risk-reducing products to people, as well as to show the risks they have. Moreover, BMS is implementing a joint resaech of a stem cell-based regenerative medicine for heart failure to assist commercialization of the technology (two patients have been successfully treated) . |
[Technology Classification]
-A004/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Structure
-BA10/Life Innovation/Drug Discovery & Diagnosis/Diagnostic Equipment
-BB08/Life Innovation/Regenerative Medicine/Heart
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BB04/Life Innovation/Medical Equipment/Medical Supplies
|
+81-6-6943-1011
info@biomarker.co.jp |
